Wednesday, February 10, 2010, 8:19pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Anika Therapeutics Inc. (ANIK)

At 4:58AM SGT: 6.49 USD   0.00 (0.00%)  
 MORE ON ANIK 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Anika Therapeutics Inc. (NasdaqNM:ANIK) Delayed quote dataEdit
Last Trade:6.49 USD
Trade Time:4:58AM SGT
Change: 0.00 (0.00%)
Prev Close:6.49
Open:N/A
Bid:6.07 x 200
Ask:7.75 x 2000
1y Target Est:18.00
Day's Range:N/A - N/A
52wk Range:3.00 - 9.25
Volume:0
Avg Vol (3m):47,093.7
Market Cap:74.23M
P/E (ttm):18.28
EPS (ttm):0.36
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ANIK to Portfolio   Download Data

 HEADLINES 
•Anika Therapeutics to Discuss Acquisition of Fidia Advanced Biopolymers During Special Conference Call Today
Business Wire (Mon, Jan 4)
•Anika Therapeutics Acquires Fidia Advanced Biopolymers: A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
Business Wire (Thu, Dec 31)
•Anika gets European approval on wrinkle product
AP (Fri, Nov 20)
•Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Business Wire (Thu, Nov 19)
•ANIKA THERAPEUTICS INC Financials
EDGAR Online Financials (Sat, Nov 7)
•ANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Nov 4)
•Anika Therapeutics Earnings Call scheduled for 9:00 am ET today
CCBN (Wed, Oct 28)
•ANIKA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
EDGAR Online (Wed, Oct 28)
•ANIKA THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Sep 15)
•ANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Aug 6)
More Headlines for ANIK...
 ANALYST 
EPS Est (next year) (Dec-09) :N/A
EPS Est (in 2 years) (Dec-10) :N/A
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices